MAFEIP is a web-based tool whose purpose is to estimate the health and economic outcomes of a large variety of social and technological innovations. From the EIP on AHA perspective, MAFEIP represents the key instrument to estimate the impact of EIP on AHA interventions.
MAFEIP enables early impact assessments of an innovative process in the health and care sector. Using this tool can help decision-makers to take informed decisions about the future design of this innovative process or about its deployment on a larger scale (this is the “decision to invest”).
MAFEIP can also help, at a later stage of the innovation development, to assess precisely its value for citizens and other stakeholders (this is the “decision to buy”).
The potential users of the MAFEIP tool are stakeholders in the health and care sectors who are willing to deploy innovative practices to improve quality of care, better accessibility or more efficient use of resources.
A renewed version of the MAFEIP tool (MAFEIP 2.0) was released at the end of 2017. Several improvements and new functionalities are based upon the results of the MAFEIP study, carried out by Open Evidence and empirica.
The launch of the new tool and the enlargement of the MAFEIP users’ community have been supported by the restyling of the MAFEIP website. The site has been redesigned, enriched with additional services oriented to the specific needs of the different stakeholders accessing the site, and made easier to use.
During the EIP on AHA Conference of Partners 2018, a specific session titled “MAFEIP 2.0: Decision to Invest, Decision to Buy” was dedicated to showcasing the new tool and illustrating how it can support evidence-based decision making in health and social care intervention design.
The session was co-chaired by Arnaud Senn, EC, DG CNECT, and by Prof Francisco Lupiáñez-Villanueva, Open Evidence Co-Founder and Director. The attendees learned from the panellists about their experiences as users of the MAFEIP tool and understood how MAFEIP has been beneficial to them.
Link to presentation during the CoP:
The MAFEIP support team at Open Evidence provides continuous technical and operational support to all those organisations that wish to use MAFEIP to assess impact and cost-effectiveness of the digital health interventions they are implementing or planning to adopt.
Open Evidence is committed to disseminate and increase the outreach of the MAFEIP community through different channels so as to expand engagement with and use of the MAFEIP tool.
In the second half of May 2018, a new Call for Use Cases will be launched. It will attract the interest of organisations which might take advantage of the MAFEIP tool both within the EIP on AHA community and beyond.
The MAFEIP team is leveraging the width of their members’ existing international networks and the multiple connections established through European funded projects to promote the use of MAFEIP across Europe.
For example, on 7th May 2018, Prof Lupiáñez-Villanueva presented the MAFEIP tool during the consortium meeting of the Do CHANGE project. Do CHANGE is an ambitious H2020 project: it aims at fostering healthy habits and improving the quality of life of cardiac patients. The project’s partners demonstrated great interest in using MAFEIP for their impact and cost-effectiveness analyses.
Regular reports of MAFEIP outputs will be released, illustrating the impact on the EIP on AHA activities.